Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "central nervous system cell membranes" refers to the biological membranes that surround all cell types within the CNS, including neurons (nerve cells) and glial cells (supporting cells such as astrocytes, oligodendrocytes, microglia, and ependymal cells)[1][2][3][4][5]. These membranes are primarily composed of a phospholipid bilayer with embedded proteins, serving as selective barriers that control the entry and exit of ions, nutrients, and signaling molecules, maintain electrochemical gradients, and are studded with specific proteins such as receptors, ion channels, and transporters[2][6]. The specialization and composition of these membranes are critical to neuronal signaling, rapid conduction (via myelination), modulation of synaptic activity, and protection of CNS homeostasis[1][2][4]. Pathological changes in these membranes, due to genetic, autoimmune, or toxic processes, can lead to neurological diseases such as multiple sclerosis, where disruption of the myelin membrane leads to impaired nerve conduction[2][5]. However, "central nervous system cell membranes" does not denote a discrete molecular entity or recognizable pharmaceutical target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system cell membranes.